This phase II trial compares the effect of immunotherapy with ipilimumab and nivolumab alone to their combination with cabozantinib in treating patients with soft tissue sarcoma that has spread from where it first started to nearby tissue, lymph鈥�
- Investigator
- Leighton A Elliott
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All